Related Experiment Video
Updated: Nov 19, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Cardiac phenotype in familial partial lipodystrophy
Abdelwahab Jalal Eldin1, Baris Akinci1,2, Andre Monteiro da Rocha3
1Division of Metabolism, Endocrinology and Diabetes (MEND), Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
Familial partial lipodystrophy (FPLD) patients with LMNA variants face higher cardiac risks, particularly arrhythmias. Studying laminopathy in FPLD using patient-derived cells reveals disease mechanisms and informs monitoring strategies.
Area of Science:
- Cardiology
- Genetics
- Cell Biology
Background:
- LMNA variants are linked to cardiac issues independently of lipodystrophy.
- Familial partial lipodystrophy (FPLD) is a condition affecting fat distribution.
- Understanding the cardiac impact of laminopathy in FPLD is crucial.
Purpose of the Study:
- To assess the cardiac impact of FPLD.
- To investigate the role of laminopathy in cardiac manifestations within FPLD patients.
- To analyze the association between LMNA variants and cardiac events in FPLD.
Main Methods:
- Retrospective cohort study of 122 FPLD patients.
- Analysis of clinical data and cardiac events.
- Proof-of-concept study using LMNA variant patient-derived cardiomyocytes (hiPSC-CMs).
Main Results:
- Patients with LMNA variants showed a higher prevalence of cardiac events and significantly increased risk of arrhythmias, including atrial fibrillation/flutter.
- Non-codon 482 LMNA variants were more strongly associated with cardiac events than codon 482 variants.
- LMNA mutant hiPSC-CMs exhibited abnormal electrical activity, including spontaneous arrhythmias and altered responses to stimulation.
Conclusions:
- Vigilant cardiac monitoring is essential for FPLD patients, especially those with LMNA variants.
- LMNA variants significantly increase the risk of cardiac arrhythmias in FPLD.
- hiPSC-CMs offer a valuable model for elucidating arrhythmia mechanisms in lipodystrophy patients with specific mutations.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cholesterol: Significance and Regulation
Considering cholesterol and...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Catabolism
Cardiomyopathy II: Dilated Cardiomyopathy

